March 27, 2017 5:37 PM ET


Company Overview of Coley Pharmaceutical Group, Inc.

Key Executives for Coley Pharmaceutical Group, Inc.

NameBoard RelationshipsTitleAge
Heather L. Davis Ph.D.18 RelationshipsVice President and Managing Director of Coley Ltd.62
Caroline Krump No RelationshipsExecutive Officer--

Coley Pharmaceutical Group, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Manfred E. Karobath M.D. 16 RelationshipsQIAGEN N.V.75
Patrick J. Langlois Ph.D. 61 RelationshipsSensorion SA71
Robert J. Hugin MBA 62 RelationshipsCelgene Corporation61
View All Board Members

Coley Pharmaceutical Group, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Coley Pharmaceutical Group, Inc. CEO Compensation
Industry Average


Amryt Pharma plc Appoints David Allmond as Chief Commercial Officer, Effective April 3, 2017
March 27, 2017 6:00 AM ET
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
March 24, 2017 11:00 AM ET
Hutchison China MediTech Limited Appoints Weiguo Su as Executive Director and Member of Technical Committee, Effective March 27, 2017
March 24, 2017 7:00 AM ET
Togo D. West Notifies Bristol-Myers Squibb Company That He Will Not Stand for Re-Election to the Board of Directors
March 23, 2017 8:32 PM ET
True Nature Holding, Inc. Appoints Leo Smith to its Non-Executive Advisory Board
March 23, 2017 6:36 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Coley Pharmaceutical Group, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at